Cochrane Hypertension
Share
The Cochrane Hypertension Group is committed to helping people make well-informed decisions about prevention and treatment of hypertension.
03/02/2026
🚨ICYMI - Updated Cochrane :
Withdrawal of antihypertensive drugs in older people 💊
https://doi.org/10.1002/14651858.CD012572.pub3
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
09/02/2025
ICYMI - Cochrane 🎺
Renin inhibitors versus angiotensin receptor blockers for primary
https://doi.org/10.1002/14651858.CD012570.pub2
04/21/2025
🆕 We've published a new Cochrane protocol:
Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
https://doi.org/10.1002/14651858.CD016144
03/04/2025
webinar recording
Debunking some of the hype in
ti.ubc.ca/drugevidence24
Dr. James Wright summarizes latest evidence on :
⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety
Click here to claim your Sponsored Listing.
Category
Contact the practice
Address
2176 Health Sciences Mall
Vancouver, BC
V6T1Z3
